-
71.发明申请Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid 审中-公开霉酚酸酯和麦考酚酸的其他酯的制备方法公开(公告)号：US20080280977A1
公开(公告)日：2008-11-13
申请号：US12218892
申请日：2008-07-18
申请人： Sandor Molnar , Csaba Szabo , Tivadar Tamas , Janos Hajko , Claude Singer , Beata Kosztya
发明人： Sandor Molnar , Csaba Szabo , Tivadar Tamas , Janos Hajko , Claude Singer , Beata Kosztya
IPC分类号： A61K31/343 , C07D307/77
CPC分类号： C07D307/88
摘要： Provided are processes for the preparation of mycophenolate mofetil and other esters of mycophenolic acid.
摘要翻译： 提供了制备霉酚酸酯和麦考酚酸的其它酯的方法。
-
72.发明授权Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof 有权嘌呤衍生物作为腺苷A1受体激动剂及其使用方法公开(公告)号：US07423144B2
公开(公告)日：2008-09-09
申请号：US11137632
申请日：2005-05-25
申请人： Prakash Jagtap , Csaba Szabo , Andrew L. Salzman
发明人： Prakash Jagtap , Csaba Szabo , Andrew L. Salzman
IPC分类号： A61K31/7056 , A61K31/7076 , A61K31/708 , C07H16/167 , C07H16/173
CPC分类号： C07H19/167 , C07D473/34 , C07H19/12
摘要： The invention relates to Purine Derivatives; compositions comprising an effective amount of a Purine Derivative; and methods for reducing an animal's rate of metabolism, protecting an animal's heart against myocardial damage during cardioplegia; or for treating or preventing a cardiovascular disease, a neurological disorder, an ischemic condition, a reperfusion injury, obesity, a wasting disease, or diabetes, comprising administering an effective amount of a Purine Derivative to an animal in need thereof.
摘要翻译： 本发明涉及嘌呤衍生物; 包含有效量的嘌呤衍生物的组合物; 以及降低动物代谢率的方法，保护动物的心脏免受心脏停搏期间的心肌损伤; 或用于治疗或预防心血管疾病，神经障碍，缺血状况，再灌注损伤，肥胖症，消耗性疾病或糖尿病，包括向有需要的动物施用有效量的嘌呤衍生物。
-
公开(公告)号：US20080199541A1
公开(公告)日：2008-08-21
申请号：US12023840
申请日：2008-01-31
CPC分类号： A61K33/04 , A61J1/06 , A61K9/0019 , A61K9/08 , A61K33/00 , A61K33/24 , A61K47/02 , A61K47/12 , B65D81/2069
摘要： The present invention provides novel stable, liquid compositions comprising chalcogenides or salts thereof. These compositions may be used for a variety of purposes, including the treatment and prevention of ischemic or hypoxic injury, as well as in the preservation of biological matter.
-
74.发明申请LIQUID CHALCOGENIDE COMPOSITIONS AND METHODS OF MANUFACTURING AND USING THE SAME 审中-公开液体氯化铝组合物及其制备方法和使用方法公开(公告)号：US20080187604A1
公开(公告)日：2008-08-07
申请号：US11868348
申请日：2007-10-05
CPC分类号： A61K33/04 , A61K9/0095 , A61K9/2013 , A61K9/2054
摘要： The present invention provides novel stable, liquid compositions comprising chalcogenides or salts thereof. These compositions may be used for a variety of purposes, including the treatment and prevention of ischemic or hypoxic injury, as well as in the preservation of biological matter.
摘要翻译： 本发明提供包含硫族化合物或其盐的新型稳定的液体组合物。 这些组合物可以用于各种目的，包括治疗和预防缺血性或缺氧性损伤以及保护生物物质。
-
![Preparation of 1H-imidazo[4,5-c]quinolin-4-amines via 1H-imidazo[4, 5-c]quinolin-4-phtalimide intermediates](/abs-image/US/2008/05/01/US20080103310A1/abs.jpg.150x150.jpg)
75.发明申请Preparation of 1H-imidazo[4,5-c]quinolin-4-amines via 1H-imidazo[4, 5-c]quinolin-4-phtalimide intermediates 审中-公开通过1H-咪唑并[4,5-c]喹啉-4-邻苯二甲酰亚胺中间体制备1H-咪唑并[4,5-c]喹啉-4-胺公开(公告)号：US20080103310A1
公开(公告)日：2008-05-01
申请号：US11974947
申请日：2007-10-16
申请人： Janos Hajko , Csaba Szabo , Piroska Kovacs
发明人： Janos Hajko , Csaba Szabo , Piroska Kovacs
IPC分类号： C07D471/04
CPC分类号： C07D471/04
摘要： The present invention provides process for the preparation of 4-amino-1H-imidazo[4,5-c]quinolines comprising the step of reacting a 1H-imidazo[4,5-c]quinolin-4-phthalimide with an amine selected from the group consisting of: alkylamine, aralkylamine, alkyldiamine, and aralkyldiamine.
摘要翻译： 本发明提供了制备4-氨基-1H-咪唑并[4,5-c]喹啉的方法，包括使1H-咪唑并[4,5-c]喹啉-4-邻苯二甲酰亚胺与选自 由烷基胺，芳烷基胺，烷基二胺和芳烷基二胺组成的组。
-
![Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one](/abs-image/US/2006/11/09/US20060252942A1/abs.jpg.150x150.jpg)
76.发明申请Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one 审中-公开制备1,2,3,9-四氢-9-甲基-3 - [（2-甲基-1H-咪唑-1-基）甲基] -4H-咔唑-4-酮的方法公开(公告)号：US20060252942A1
公开(公告)日：2006-11-09
申请号：US11482486
申请日：2006-07-07
IPC分类号： C07D403/02
CPC分类号： C07D403/06 , C07D209/88
摘要： A process for preparing ondansetron by transamination of an ondansetron structural analog that can be readily prepared conveniently by a Mannich reaction is provided. The process represents an improvement upon known procedures for making ondansetron by transamination because of its rapid rate, selectivity and the ease with which the product can be isolated from the reaction mixture.
摘要翻译： 提供了可以通过Mannich反应方便地制备的昂丹司琼结构类似物的转氨制备昂丹司琼的方法。 该方法代表了通过转氨制备昂丹司琼的已知方法的改进，因为它具有快速的速率，选择性和易于与反应混合物分离产物。
-
77.发明申请公开(公告)号：US20060194876A1
公开(公告)日：2006-08-31
申请号：US11329915
申请日：2006-01-10
申请人： Laszlo Kovacs , Csaba Szabo , Erika Molnarne , Claude Singer
发明人： Laszlo Kovacs , Csaba Szabo , Erika Molnarne , Claude Singer
IPC分类号： A61K31/205 , C07C59/255
CPC分类号： C07C215/54 , C07C59/255 , C07C213/00 , C07C213/10
摘要： The present invention provides substantially pure Tolterodine.
摘要翻译： 本发明提供基本上纯的托特罗定。
-
![Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one](/abs-image/US/2006/08/29/US07098345B2/abs.jpg.150x150.jpg)
78.发明授权公开(公告)号：US07098345B2
公开(公告)日：2006-08-29
申请号：US10425450
申请日：2003-04-29
IPC分类号： C07D233/58
CPC分类号： C07D403/06 , C07D209/88
摘要： A process for preparing ondansetron by transamination of an ondansetron structural analog that can be readily prepared conveniently by a Mannich reaction is provided. The process represents an improvement upon known procedures for making ondansetron by transamination because of its rapid rate, selectivity and the ease with which the product can be isolated from the reaction mixture.
-
79.发明申请Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same 审中-公开盐酸多佐胺的无定形和结晶形式及其制备方法公开(公告)号：US20060173068A1
公开(公告)日：2006-08-03
申请号：US11334991
申请日：2006-01-18
申请人： Judith Aronhime , Csilla Nemethne Racz , Adrienne Kovacsne-Mezei , Csaba Szabo , Laszlo Kovacs , Lorant Gyuricza
发明人： Judith Aronhime , Csilla Nemethne Racz , Adrienne Kovacsne-Mezei , Csaba Szabo , Laszlo Kovacs , Lorant Gyuricza
IPC分类号： A61K31/382 , C07D495/02
CPC分类号： C07D495/04
摘要： The invention provides an amorphous form of Dorzolamide hydrochloride, processes for the preparation of amorphous Dorzolamide hydrochloride, processes for making Form II from amorphous Dorzolamide HCl, a crystalline form of Dorzolamide hydrochloride, Form IV, process for making Form IV, and pharmaceutical compositions of amorphous Dorzolamide hydrochloride, Dorzolamide hydrochloride Form II and Dorzolamide hydrochloride Form IV.
摘要翻译： 本发明提供了无定形形式的多佐胺酰胺盐酸盐，制备无定形多佐胺酰胺盐酸盐的方法，由无定形多佐胺酰胺HCl制备形式II的方法，盐酸多佐胺酰胺的结晶形式，IV型，制备IV型的方法， 盐酸多佐胺，盐酸多佐胺酰胺II型和多佐胺酰胺盐酸盐形式IV。
-
公开(公告)号：US20060155132A1
公开(公告)日：2006-07-13
申请号：US11326719
申请日：2006-01-06
申请人： Laszlo Kovacs , Csaba Szabo , Erika Molnarne , Adrienne Kovacsne-Mezei , Claude Singer , Judith Aronhime
发明人： Laszlo Kovacs , Csaba Szabo , Erika Molnarne , Adrienne Kovacsne-Mezei , Claude Singer , Judith Aronhime
IPC分类号： C07D495/02
CPC分类号： C07D495/04
摘要： Processes for the preparation of dorzolamide hydrochloride and an intermediate of Formula IV, are provided.
-
-
-
-
-
-
-
-
-
搜索结果
109 条记录 (耗时 0.07 秒)
